News

Q1 2025 Earnings Call Transcript April 30, 2025 GSK plc beats earnings expectations. Reported EPS is $1.13, expectations were ...
GSK said it remains confident in its ability to absorb the financial impact of potential US pharmaceutical tariffs as it ...
Dr. Kate Knobil joins the biotech as it looks to combat a viral infection that can be dangerous to patients with the lung ...
Feedback notes the proliferation of AI company logos, and agrees with one blogger's claim that many bear a striking ...
GSK PLC GSK shares advanced 3.60% to £14.84 Wednesday, on what proved to be an all-around favorable trading session for the ...
GSK PLC closed 21.47% short of its 52-week high of £18.24, which the company reached on May 16th.
Check out the Launch Trailer for Lost for Swords, a card-based roguelike deck-builder developed by Max Bytes. The rooms players will explore will be based on the cards in their decks to add ...
GSK has secured the first regulatory approval for Blenrep since the antibody-drug conjugate’s global market withdrawal in 2022. The U.K.’s Medicines and Healthcare products Regulatory Agency ...
GSK (GSK) plc announced the authorization of Blenrep by the Medicines and Healthcare products Regulatory Agency. “In the UK, Blenrep is approved for the treatment of adults with multiple myeloma ...
Some Delaware Supreme Court justices signaled they may be skeptical of a bid by GSK Plc, Pfizer Inc. and other drugmakers to overturn a judge who allowed more than 80,000 lawsuits to proceed to ...
GSK’s five-in-one meningococcal vaccine has been recommended by the US Centers for Disease Control and Prevention’s (CDC) immunisation panel as part of the adolescent meningococcal vaccination ...